Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Philippines | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Venezuela | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Sandoz | en
Novartis Foundation | en
Egypt | en
South Africa | en
Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Philippines

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Venezuela | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Novartis Foundation | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
    • About 
      • Novartis in Philippines 
      • Strategy 
      • Diversity and Inclusion 
      • People and Culture 
      • Products 
      • Country Leadership Team 
      • Contact 
      Novartis Philippines About About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Patient resources 
      • Products 
      • Adverse Event Reporting 
      Patients and Caregivers Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Healthcare Professionals Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      ESG ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      A photo of people in a meeting hall News
    • Careers 
      • Career Search 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity and Inclusion 
      • Career Programs 
      • Awards and Recognition 
      Woman wearing a red shirt Careers
    • Coronavirus 
      Coronavirus under the microscope Coronavirus
    Home Novartis Philippines Home

Stories

  • Novartis Philippines launches PIK3CA Testing Program for Breast Cancer 2.jpeg
    Sep 23, 2022
    Novartis supports the Southeast Asian Breast Cancer Symposium
  • Meeting of People
    Education & Awareness
    Mar 14, 2022
    Asia Pacific Patient Innovation Summit: Philippines Outcome Report 2021
    Education & Awareness
  • World Spine Day
    Education & Awareness
    Mar 2, 2022
    Bamboo Spine in Ankylosing Spondylitis
    Education & Awareness
  • Caring For Employee Mental Health
    Education & Awareness
    Mar 2, 2022
    Mental Health, Migraine and Workplace Culture in the time of COVID-19
    Education & Awareness
  • Image: Filipino Delegates to the Novartis Next Generation Scientist Program and Biotechnology Leadership Camp
    Hope
    Mar 2, 2022
    Building A Science And Innovation Nation
    Hope

Novartis Philippines

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2023 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Philippines